Woodstock Sterile Solutions
United States 177 employees Updated 9 July 2026
Woodstock Sterile Solutions is a finished-dose manufacturer based in United States. It appears in 2 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC) and DIGEMAPS (DO). Its GMP standing is certified by ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 13 October 2022 as NAI.
2
registered plants
1 with an FDA FEI number
2
filings
across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 13 October 2022 NAI US FDA
- 3 July 2018 NAI US FDA
- 16 November 2015 VAI US FDA
- 22 August 2014 VAI US FDA
- 16 May 2013 NAI US FDA
- 7 May 2012 VAI US FDA
- 20 April 2011 NAI US FDA
- 10 November 2010 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| WOODSTOCK, United States | Not on file |
| Woodstock, United States | 1419377 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| ARCSA (EC) | 1 | None |
| DIGEMAPS (DO) | 1 | None |
| ANVISA (Brazil) | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Woodstock Sterile Solutions comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was NAI, on 13 October 2022.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates